Study data published in the journal NPJ Vaccines support the feasibility of vaccines for eliminating or reducing the need for surgery and antibiotics for severe gum disease, Science Daily reported.
The investigational vaccine is being developed by researchers at the University of Melbourne in collaboration with CSL.
Based on the study results, the investigators plan to initiate clinical studies of the vaccine as early as 2018.
"We currently treat periodontitis with professional cleaning sometimes involving surgery and antibiotic regimes," remarked study author Eric Reynolds, adding "these methods are helpful, but in many cases the bacterium re-establishes in the dental plaque causing a microbiological imbalance so the disease continues."
"We hold high hopes for this vaccine to improve quality of life for millions of people," Reynolds continued.
To read more NewsPoints articles, click here.